Home › Schizophrenia › Oklahoma
Schizophrenia clinical trials in Oklahoma
4 studies for Schizophrenia are looking for participants at sites in Oklahoma.
Cities in Oklahoma
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Sooner Clinical Research, Norman
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Nov 3, 2026 · NCT06229210Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- The Rivus Wellness & Research Institute, Oklahoma City
- Local Institution - 0052, Tulsa
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT07379827Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Local Institution - 0047, Oklahoma City
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Oct 30, 2026 · NCT07686263Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- Reviva site, Oklahoma City
RecruitingPhase 3Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Dec 19, 2024 · NCT05184335From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.